Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARStandard

DUODOTE

ATROPINE; PRALIDOXIME CHLORIDE

Standard Dose
2.1MG/0.7ML;600MG/2ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DUODOTE is listed in Drugs@FDA under application 021983 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE; PRALIDOXIME CHLORIDE Form and strength INJECTABLE;INTRAMUSCULAR - 2.1MG/0.7ML;600MG/2ML Sponsor MMT Submission history Latest submission status date: 2022-05-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview DUODOTE is listed in Drugs@FDA under application 021983 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE; PRALIDOXIME CHLORIDE Form and strength INJECTABLE;INTRAMUSCULAR - 2.1MG/0.7ML;600MG/2ML Sponsor MMT Submission history Latest submission status date: 2022-05-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.